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Abstract
Background: Individuals with impaired immunity are at higher risk of perianal diseases. Concerning complex anal
fistulas impaired healing and complication rates are also higher. Definitive treatment of a fistula aims controlling
the purulent discharge and prevents its recurrence. It depends mainly on the trajectory of the fistula and the
underlying disease.
We present a case of a HIV-positive patient with a complex extrasphincteric anal fistula who was treated success-
fully with fibrin glue application. We further, discuss tips and tricks when applying fibrin glue as plugging material
in complex anal fistulas.
Case presentation: A sixty-one-year-old HIV-positive male referred to us for warts and extrasphincteric fistula.
Because of the patients’ immunological status, we opted against surgery and recommended fibrin glue plugging.
The patient was discharged the same day. A follow-up examination was performed 5 days after the initial fibrin
glue application showing that the fistula canal was obstructed. Three months and a year post-intervention the
fistula tract remains closed.
Conclusion: The best treatment for a disease gives at least the same result with the other treatments with
minimised risk for the life of the patient and minimal application effort. Conservative closure of fistula with fibrin
plugging is simple, safe and with less morbidity than surgery. Our patient was successfully treated without
endangering his life despite his precarious medical state. Not everybody believes in the effectiveness of fibrin glue
application, however we consider this solution in cases of complex fistulas at least as primary procedure in special
populations such as the immunosupressed.
Background
Individuals with diseases that reduce the body’s immu-
nity -such as AIDS or cancer- are at a higher risk of
anal abscess and fistula formation [1]. However, despite
the higher incidence of fistula formation, no differences
were observed concerning the healing time in simple fis-
tulas [2]. On the contrary, healing and complication
rates were altered in complex fistulas [3].
In all individuals, definitive treatment of a fistula aims
to control the purulent discharge and prevent its recur-
rence. Treatment depends mainly on the trajectory of
the fistula and the underlying disease leading to the fis-
tula formation [4,5]. The standard treatments that can
be used are various, mostly surgical in nature, including
fistulotomy, excision of the external fistula tract, closure
of the internal opening, curettage, endorectal advance-
ment flap, a cutting seton or immediate reconstruction
[6].
Fibrin glue pluging is a method explored in recent
years in various types of fistulas with great success [7-9].
Recently, fibrin glue has been applied in perianal fistulas
with diverse success rates [4,5,10].
We present a special case of a HIV-positive patient
with a complex extrasphincteric anal fistula who was
treated successfully with fibrin glue application. We * Correspondence: papavramidis@hotmail.com
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as plugging material in fistulas.
Case presentation
A sixty-one-year-old Caucasian male referred to our
department suffering from anal pain and a combination
of mucopurulent and stercoraceous discharges. The
patient is HIV-positive with very low viral load, T4 577
c/ul, T8 1006 c/ul and T4/T8 = 1. During clinical exam-
ination, warts were found in the anal region. The exter-
nal orifice of a fistula was in the right lateral wall of the
internatal region. Prior any intervention, a fistulography
(Figure 1) and a colonoscopy were performed as initial
evaluation to help rule out any other disease process in
the rectum. Fistulography revealed an extrasphincteric
fistula with a 5 cm length and a 1.5 mm breadth. Colo-
noscopy didn’t reveal any pathological findings. Because
of the patients’ immunological status, we opted against
the surgical decision that required a colostomy forma-
tion, and instead recommended the closure of the fistula
by using a fibrin glue plug. Prior fibrin glue application,
on the same session, a new fistulography was performed,
aiming to identify the internal orifice of the fistula and
place a catheter proximal to this orifice, in order to
i n f u s et h eg l u e( S t a r t i n gf r o mt h ei n t e r n a lo r i f i c ea n d
coming out). During fistulography, we discovered the
existence of a second anal fistula. As show in the
schema (Figure 2), both fistulas shared a common inter-
nal orifice in the rectal wall. No acute purulence or
inflammation of the fistulas was oberserved at the time
of intervention. The two fistulas were managed sepa-
rately. The anal fistula was managed by a seton-type
prolen-0 stitch. Following the seton placement, we
catheterized the external orifice of the extrasphincteric
fistula, we were then able to place a catheter near the
internal orifice of the fistula in order to infuse the fibrin
glue. The fibrin sealant Beriplast P (Behring, Marburg,
Germany) was used as fistula plug. The kit contains
freeze-dried fibrinogen and aprotinin solution and
freeze-dried thrombin and calcium chloride. These sub-
stances are mixed to form two components–sealer and
thrombin solution–that are kept in two separate syr-
inges. Local application of the components was accom-
plished under radioscopic vision via a catheter passed
through fistula. The two components were injected with
separate syringes, and simultaneous mixing at the cathe-
ter tip led to rapid coagulation and mechanically stable
fibrin clot formation inside the fistula tract. Immediate
post-interventional fistulography showed to evidence of
fistula tract. The patient was discharged the same day. A
follow-up examination was performed 5 days after the
initial fibrin glue application. Catheterization of the
internal orifice of the fistula showed that the fistula
canal was closed. Three months and a year after the
initial intervention a new radioscopic examination was
scheduled proving that both anal fistulas were success-
fully closed.
Discussion
Anal fistulas are divided into 4 categories, with the
suprasphincteric category being the rarest and repre-
senting approximately 1% of the total number of fistulas.
The present fistula additionally, enters in the category of
“complex” fistulas after the definition given by Loung-
narath et al [11]. By this definition “complex” annals fis-
tulas are those in which treatment by simple fistulotomy
would result in significant impairment of continence.
This category generally consists of high transsphincteric,
suprasphincteric and extrasphincteric fistulas. The treat-
ment of complex anal fistulas is one of the most chal-
lenging aspects of coloproctology and colorectal surgery.
The complexity of the present case is aggravated by
the fact that the patient is HIV-positive. Approximately
30% of patients with HIV develop anorectal abscesses
Figure 1 Fistulography showing the tractus of the fistula.
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arise from the dentate line in similar locations to
human immunodeficiency virus-negative patients [12].
Anorectal procedures (for anal condylomata, fistula in
ano, hemorrhoids, and perirectal abscess) are the most
common operations performed in HIV-patients. No pro-
spective data are available on operative morbidity and
mortality in HIV-positive and HIV-negative patients. In
retrospectives studies, investigators found a high inci-
dence of serious wound complications after anorectal
surgery and urged non-operative treatment for most
anorectal diseases in HIV-infected patients [2,3].
Although there is currently no scientific data on the
prevalence of surgical complications among HIV
patients compared to non-infected patients in colorectal
surgery, it is more safely to avoid any type of major sur-
gical treatment, as these patients have a weakened
immune system. In this perspective, alternatives to con-
ventional surgery were considered to the present patient.
Alternative to conventional surgery in complex anal
fistulas are considered the use of fibrin glue (autologous
or commercial) and the use of a biologic fistula plug
(Surgisis®AFP™). Among those two choices we chose the
first. Our choice was based on the fact that we had no
experience with Surgisis and that all studies employing
this material date less than 5 years, not permitting to
evaluate the long-term results [13,14]. On the other
hand, fibrin glue application is a safe, cheap,
reproducible, pain-free procedure, which eliminates the
possibility of anal incontinence and can be performed
under local anaesthesia [15]. The fibrin glue application
in the treatment of anal fistula is the guaranteed preser-
vation of the sphincters, so it avoids the risk of inconti-
nence, and creates minimal stress for the patient
[4,5,10]. However, a final question arises -mainly theore-
tically- when coming to fibrin glue application: autolo-
gous or commercial? To our opinion commercial
sealants have an advantage over autologous ones. Our
impression seems to correlate well with the meta-analy-
sis of Hammond et al [10]. According to this meta-ana-
lysis commercial sealants have been shown to bond
more consistently -by up to 10 times stronger than
autologous when compared in vitro-, take less time to
prepare and do not require autologous blood transfu-
sion. This was the reason why commercial fibrin glue
was employed for plugging the anal fistula in the present
case.
Tips and tricks
We believe that in the present case we had a successful
closure of the fistula due to tips and tricks that we have
extracted from our experience both in simple anal fistu-
las and fibrin glue application. Patients’ history and old
hospitalizations have to be considered carefully in order
to determine, if possible, the aetiology of the fistula and
the predisposing factor. The visualization of fistulas’
Figure 2 Schematic presentation of the fistula in correlation with the MRI images.
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-either surgical or not-. The preoperative evaluation
includes colonoscopy, fistulography and MRI of the pel-
vis. In that way, the tract of the fistula is known before
any intervention. Once the fistula is a “complex” one,
then adequate treatment is applied after considering the
general condition of the patient. In case of fibrin glue
application, we perform no pre-operative bowel prepara-
tion. This strategy is in the same context as for all colo-
nic operations in our department: intact colonic flora
offers better healing [16]. Immediately, before the fibrin
glue application we like to perform a new fistulography.
Once the fistula tract is visualized we perform blunt
curettage. Mechanical curettage stops when blood exits
the external orifice of the fistula. After that, chemical
cleansing with hydrogen peroxide follows aiming both
in introducing oxygen radicals in the fistula (bactericide)
and in achieving haemostasis. Following that, catheteri-
zation of the fistula tract is achieved with a catheter that
has a slightly smaller in diameter than the fistula. A
small quantity of radioopaque material is introduced
into the catheter in order to assure that its tip is placed
in proximity to the internal orifice. The fibrin glue is
then prepared by an assistant and a plastic double-
lumen Y-connector joins the two syringes. The connec-
tor is connected to the catheter introduced in the fistula
and secured. Coordination is primordial in the last
phase of application since with one hand we should
push the glue through the syringe into the fistula, while
with the other we slowly retract the catheter tip through
the fistula. To our opinion this is the most important
phase since it is the only one requiring familiarization
with the material. Failure to coordinate the two move-
ments will lead to misplacement of the glue and failure
of the procedure. A large drop of glue should be
reserved to seal the external orifice of the fistula. Anti-
biotics and immobilization of the patient -in our opi-
nion- offer nothing as post-interventional measures.
Conclusion
The best treatment for a disease is the one that gives at
least the same result with the others with minimised
risk for the life of the patient and minimal application
effort. Conservative closure of fistula with fibrin tissue
sealant is simple and especially in recurrent and difficult
cases. Although anal fistula surgery is associated with
considerable morbidity, mainly related to anal inconti-
nence, our patient was successfully treated with the
minimally invasive method by using fibrin glue, without
endangering his life despite his precarious medical state.
Despite the fact that not everybody believes in the effec-
tiveness of fibrin glue application on anal fistulas, we
suggest considering this solution in cases of complex
fistulas at least as primary procedure in special popula-
tions such as the immunosupressed.
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